In:
Nuklearmedizin, Georg Thieme Verlag KG, Vol. 23, No. 02 ( 1984), p. 77-79
Abstract:
In 91 patients with a suspicion of pheochromocytoma 96 scintigraphies with 131I-metaiodobenzylguanidine were performed. The distribution of this radiopharmaceutical agent was studied. In about 71% we found uptake in the liver, in about 20% in the spleen and in about 6% in the gastrointestinal tract. In 13% of our patients a normal tracer uptake in the adrenal medulla was observed. In 23 patients adrenal or extra-adrenal lesion (s) were localized correctly, whereas one false-positive and one false-negative scintigramme was obtained. The 131I-MIBG imaging of adrenal and extra-adrenal, benign and malignant pheochromocytomas and adrenomedullary hyperplasia is highly specific. In the treatment of pheochromocytomas more experience is needed to present final results, but especially in malignant pheochromocytomas 131I-MIBG therapy may be useful.
Type of Medium:
Online Resource
ISSN:
0029-5566
,
2567-6407
DOI:
10.1055/s-0038-1624175
Language:
English
Publisher:
Georg Thieme Verlag KG
Publication Date:
1984
Permalink